{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:27:32Z","timestamp":1767835652051,"version":"3.49.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T00:00:00Z","timestamp":1365033600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0059546","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T22:24:56Z","timestamp":1365114296000},"page":"e59546","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["Cost-Effectiveness of Quantiferon\u00ae-TB Gold-In-Tube Versus Tuberculin Skin Testing for Contact Screening and Treatment of Latent Tuberculosis Infection in Brazil"],"prefix":"10.1371","volume":"8","author":[{"given":"Ricardo Ewbank","family":"Steffen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ros\u00e2ngela","family":"Caetano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcia","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diogo","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossini","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayara","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra Teixeira","family":"de Abreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dick","family":"Menzies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anete","family":"Trajman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,4,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0140-6736(12)60727-2","article-title":"Scaling up interventions to achieve global tuberculosis control: progress and new developments","volume":"379","author":"M Raviglione","year":"2012","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1001\/jama.293.22.2767","article-title":"Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally","volume":"293","author":"C Dye","year":"2005","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1098\/rsif.2007.1138","article-title":"Eliminating human tuberculosis in the twenty-first century","volume":"5","author":"C Dye","year":"2008","journal-title":"J R Soc Interface"},{"key":"ref4","first-page":"498","article-title":"Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results","volume":"12","author":"D Menzies","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref5","unstructured":"International Union Against Tuberculosis Committee on Prophylaxis (1982) Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUATL trial: International Union Against Tuberculosis Committee on Prophylaxis. Bull World Health Organ: 555\u2013564."},{"key":"ref6","first-page":"847","article-title":"How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?","volume":"3","author":"GW Comstock","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref7","first-page":"551","article-title":"Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment","volume":"14","author":"A Trajman","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref8","first-page":"1270","article-title":"Classics in infectious diseases. The etiology of tuberculosis: Robert Koch. Berlin, Germany 1882","volume":"4","author":"R Koch","year":"1982","journal-title":"Rev Infect Dis"},{"key":"ref9","first-page":"146","article-title":"La voie intradermique en tuberculinoth\u00e9rapie","volume":"20","author":"M Mantoux","year":"1912","journal-title":"Presse Med"},{"key":"ref10","first-page":"656","article-title":"Skin test reactivity to mycobacterial antigens parallels the phylogenetic structure of their genus","volume":"5","author":"AL Bierrenbach","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref11","unstructured":"Cobelens FG, Menzies D, Farhat M (2007) False-positive tuberculin reactions due to non-tuberculous mycobacterial infections. Int J Tuberc Lung Dis 11: 934\u2013935;author reply 935."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/314075","article-title":"What does tuberculin reactivity after bacille Calmette-Guerin vaccination tell us?","volume":"31","author":"D Menzies","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/clinids\/17.6.968","article-title":"The tuberculin skin test","volume":"17","author":"RE Huebner","year":"1993","journal-title":"Clin Infect Dis"},{"key":"ref14","first-page":"895","article-title":"Tuberculin reactivity and the risk of tuberculosis: a review","volume":"4","author":"RE Watkins","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"M Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"ref16","first-page":"962","article-title":"Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico","volume":"13","author":"JL Burgos","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archinternmed.2008.524","article-title":"Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers","volume":"169","author":"MA de Perio","year":"2009","journal-title":"Arch Intern Med"},{"key":"ref18","first-page":"471","article-title":"Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection","volume":"14","author":"S Deuffic-Burban","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1378\/chest.06-2728","article-title":"Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany","volume":"131","author":"R Diel","year":"2007","journal-title":"Chest"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1183\/09031936.00145906","article-title":"Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis","volume":"30","author":"R Diel","year":"2007","journal-title":"Eur Respir J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/thx.2009.119677","article-title":"Cost\u2013effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries","volume":"65","author":"AB Hardy","year":"2010","journal-title":"Thorax"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF03256289","article-title":"Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan","volume":"12","author":"A Kowada","year":"2008","journal-title":"Mol Diagn Ther"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Linas BP, Wong AY, Freedberg KA, Horsburgh Jr CR (2011) Priorities for Screening and Treatment of Latent Tuberculosis Infection in the United States. Am J Respir Crit Care Med.","DOI":"10.1164\/rccm.201101-0181OC"},{"key":"ref24","first-page":"1414","article-title":"Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts","volume":"12","author":"F Marra","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref25","first-page":"16","article-title":"Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis","volume":"11","author":"O Oxlade","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Pareek M, Watson JP, Ormerod LP, Kon OM, Woltmann G, et al.. (2011) Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Infect Dis.","DOI":"10.1016\/S1473-3099(11)70069-X"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2466-10-7","article-title":"Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis","volume":"10","author":"A Pooran","year":"2010","journal-title":"BMC Pulm Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1469-0691.2011.03555.x","article-title":"Guidelines on interferon-gamma release assays for tuberculosis infection: concordance, discordance or confusion?","volume":"17","author":"CM Denkinger","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"ref29","unstructured":"Programa Nacional de Controle da Tuberculose (2010) Manual de Recomenda\u00e7\u00f5es para o Controle da Tuberculose no Brasil."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices","volume":"8","author":"A Zwerling","year":"2011","journal-title":"PLoS Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1473-3099(08)70071-9","article-title":"Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis","volume":"8","author":"J Morrison","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1164\/ajrccm.161.3.9902005","article-title":"Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis","volume":"161","author":"K Schwartzman","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e4057","DOI":"10.1371\/journal.pone.0004057","article-title":"Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults","volume":"3","author":"DW Dowdy","year":"2008","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e14014","DOI":"10.1371\/journal.pone.0014014","article-title":"Patients' costs and cost-effectiveness of tuberculosis treatment in DOTS and non-DOTS facilities in Rio de Janeiro, Brazil","volume":"5","author":"R Steffen","year":"2010","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/00185868.1985.9948393","article-title":"Life cycle costing in hospitals. How to provide quality systems cost effectively","volume":"63","author":"PF Slowiak","year":"1985","journal-title":"Hosp Top"},{"key":"ref36","unstructured":"Edejer TT-T, World Health Organization. (2003) Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization. xiii, 312, 318 p."},{"key":"ref37","unstructured":"Ministerio da Sa\u00fade (2010) S\u00e9rie hist\u00f3rica do n\u00famero de casos novos de tuberculose. Brasil, Regi\u00f5es e Unidades Federadas de resid\u00eancia por ano diagn\u00f3stico (1990 a 2010)."},{"key":"ref38","unstructured":"Gold MR (1996) Cost-effectiveness in health and medicine. New York: Oxford University Press. xxiii, 425 p."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.7326\/0003-4819-127-12-199712150-00001","article-title":"Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis","volume":"127","author":"SR Salpeter","year":"1997","journal-title":"Ann Intern Med"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Mancuso JD, Niebuhr DW, Frick KD, Keep LW, Anderson KM (2011) Cost-effectiveness analysis of targeted and sequential screening strategies for latent tuberculosis. Int J Tuberc Lung Dis 15: 1223\u20131230, i.","DOI":"10.5588\/ijtld.10.0542"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF03256394","article-title":"Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-alpha antagonist therapy","volume":"14","author":"A Kowada","year":"2010","journal-title":"Mol Diagn Ther"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF03256378","article-title":"Cost effectiveness of interferon-gamma release assay versus chest X-ray for tuberculosis screening of BCG-vaccinated elderly populations","volume":"14","author":"A Kowada","year":"2010","journal-title":"Mol Diagn Ther"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1164\/rccm.2306004","article-title":"Isoniazid for latent tuberculosis infection: approaching 40 and reaching its prime","volume":"168","author":"CM Nolan","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1164\/ajrccm\/137.1.215","article-title":"Isoniazid for the tuberculin reactor: take it or leave it","volume":"137","author":"J Tsevat","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","article-title":"6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"T Samandari","year":"2011","journal-title":"Lancet"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1371\/journal.pmed.0040208","article-title":"Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions?","volume":"4","author":"M Pai","year":"2007","journal-title":"PLoS Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1590\/S1413-86702004000600006","article-title":"Risk of tuberculosis among household contacts in Salvador, Bahia","volume":"8","author":"AC Lemos","year":"2004","journal-title":"Braz J Infect Dis"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1164\/rccm.200303-390OC","article-title":"Use of isoniazid for latent tuberculosis infection in a public health clinic","volume":"168","author":"PA LoBue","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"ref49","first-page":"991","article-title":"Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study","volume":"117","author":"DE Kopanoff","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis","volume":"37","author":"R Diel","year":"2011","journal-title":"Eur Respir J"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0059546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T22:05:57Z","timestamp":1588975557000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0059546"}},"subtitle":[],"editor":[{"given":"David W.","family":"Dowdy","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,4]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0059546","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,4]]}}}